Testosterone Concentrations in Women Aged 25–50 Years: Associations with Lifestyle, Body Composition, and Ovarian Status

MF. Sowers, J. L. Beebe, D. McConnell, John Randolph and M. Jannausch

From the Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
While there is substantial evidence of the importance of endogenous and exogenous estrogen in reproductive health and chronic disease, there is little consideration of androgens in women's health. In the Michigan Bone Health Study (1992–1995), the authors examined the correlates of testosterone concentrations in pre- and perimenopausal women (i.e., age, menopausal status, body composition, and lifestyle behaviors) in a population-based longitudinal study including three annual examinations among 611 women aged 25–50 years identified through a census in a midwestern community. Current smokers had the highest testosterone concentrations with decreasing values in former and nonsmokers (p = 0.0001). Body composition measures (body mass index, body fat (%), weight (kg), lean body mass (kg), and fat mass (kg)) were significantly and positively associated with total testosterone concentrations in a dose-response manner. Hysterectomy with oophorectomy was associated with significantly lower testosterone concentrations. Alcohol consumption, physical activity, and dietary macronutrient intake were not associated with testosterone concentrations. This is one of the first studies to examine correlates of serum testosterone concentrations in anticipation of the growing interest in the role of androgens in women's health. The greater circulating levels of testosterone in obese women and smokers suggest that testosterone concentrations should be considered in the natural history of disease conditions where obesity and smoking are risk factors, including cardiovascular disease.

alcohol drinking; body composition; body mass index; hysterectomy; ovariectomy; smoking; testosterone

Abbreviations: DEXA, dual energy x-ray absorptiometry; MET, metabolic equivalent.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Estrogens and their effect on reproductive health and chronic diseases, including cardiovascular disease and cancers, particularly breast cancer, have been the overwhelming focus of hormone studies in women (1Go). In contrast, there is relatively little information about the role of androgens in women's health. However, testosterone products are being increasingly promoted to women in the lay press as a means of increasing well-being.

Testosterone is the most important circulating and naturally occurring androgen in both men and women. In women, testosterone is produced primarily through peripheral conversion of androstenedione (50 percent) with the remainder of production concentrated in the ovary (25 percent) and adrenal cortex (25 percent) (2Go). During pregnancy, the placenta may also serve as a source of the hormone (3Go).

In women, abnormally high levels of testosterone have been associated with hirsutism and polycystic ovary syndrome (2Go). Hirsutism is a consequence of increased production of testosterone or testosterone precursors (dehydroepiandrosterone, 3*-androstanediol, or androst-4-ene-3,17-dione (3Go)) and depression of sex hormone binding globulin (2Go). Circulating levels of free to total testosterone in hirsute women are double those of nonhirsute women (2Go). Polycystic ovary syndrome is related to ovulatory dysfunction and is a common cause of female infertility (2Go).

Testosterone concentrations have been evaluated for their associations with chronic diseases. Serum levels of testosterone have been suspected in the etiology of breast cancer of postmenopausal women. Zeleniuch-Jacquotte et al. (4Go) reported an increased risk of breast cancer with increasing concentrations of serum total testosterone (unadjusted p for trend < 0.05). However, this trend was no longer significant after adjustment for total estradiol concentrations and the percent of sex hormone binding globulin-bound estradiol. Nonetheless, those authors speculated that testosterone or its metabolites might still play a role in breast cancer etiology by altering the availability of estrogens, by competitively binding with sex hormone binding globulin, and/or by acting as an estrogen precursor. Likewise, androgen concentrations have been associated with insulin levels and diabetes mellitus (5Go). However, a temporal sequence between higher levels of androgen and increased insulin levels has not been firmly established, as higher androgen concentrations may result in increased insulin resistance or increased insulin production may stimulate androgen production in the ovary (6Go). Sowers et al. (7Go) have reported an association of osteoarthritis and serum testosterone concentrations in women aged 25–45 years.

Numerous studies have examined factors that influence testosterone concentrations in men, and these may provide an indication of the factors that influence or are associated with testosterone concentrations in women. In men, older age has been consistently associated with declining levels of testosterone (8Go, 9Go). Lower testosterone concentrations were associated with increased body mass (8Go). Smoking was also associated with increased concentrations of serum testosterone in men, whereas alcohol consumption and moderate physical activity do not appear to be associated with variation in testosterone concentrations (8Go, 10Go).

Using testosterone concentrations measured at three consecutive annual examinations in a longitudinal study, we describe the factors that are associated with those testosterone levels in pre- and perimenopausal Caucasian women. The study examined total serum testosterone concentrations in relation to the following: 1) lifestyle variables, including smoking behavior, alcohol consumption, dietary intake, and amount of physical activity; 2) changes in ovarian function, specifically exogenous hormone use and hysterectomy; 3) age, and 4) body composition and body topology. This is one of the few papers to describe correlates of testosterone concentrations in a population-based study of women and the only one that focuses largely on pre- and perimenopausal women.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Study population
The measures used in this study were collected as part of the longitudinal Michigan Bone Health Study (11Go). Briefly, in 1988, 542 premenopausal Caucasian women, aged 20–40 years, were recruited for participation. These women represented more than 80 percent of the age-eligible female offspring listed in the family records of the Tecumseh, Michigan, Community Health Study (1959–1972). Age-eligible women whose parents had not been participants of the original Tecumseh Community Health Study were added in 1992. There were 135 female residents who were contacted using a population-based sampling frame (Kohl's directory) that included age, name, address, and telephone number, and of these, 122 were enrolled.

A total of 664 women (aged 25–45 years) were eligible for participation in the subsequent examinations that began in 1992–1993. Participation varied according to pregnancy status, willingness to participate in any given year, and availability to participate in the examination time window. There were 589 women (89 percent) in the first examination, 575 women (87 percent) in the second examination, and 542 women (82 percent) in the third examination. There were 511 women (77 percent) participating in all three rounds, and 85 percent (561 women) provided data from at least two examinations.

Measurements
Testosterone levels. Women were evaluated annually on the anniversary of their initial assessment (±1 month). At each examination, blood was drawn in days 3–7 of the follicular phase of the menstrual cycle and after an 8-hour fast. For women not normally menstruating within 3 months of the examination, blood was drawn after fasting and indexed to the anniversary date of their first annual examination. Serum was frozen at -80°C. Total testosterone was assessed with a solid-phase 125I radioimmunoassay based on a testosterone-specific antibody immobilized to the wall of a polypropylene tube. The assay precision was ±15.5 percent.

Behavioral characteristics. The annual examinations included the administration of health questionnaires. Smoking status was based on questionnaires and women were categorized as never, former, or current smokers. The participants were classified by their self-reported consumption of alcohol as 1) nondrinkers, 2) currently consuming <=10 g (less than one drink) per week, 3) currently consuming 10–17 g per week, and 4) currently consuming >17 g (more than two drinks) per week. Groups 2, 3, and 4 are the first, second, and third tertiles, respectively, among those who report consuming alcohol at least once a week.

Annually, women reported physical activity during the previous week, previous July, and previous December. These data were averaged, and an algorithm modeled on the Stanford Five City instrument was used to indicate average weekly activity in metabolic equivalents (METs) (12Go). One MET is the energy consumed per minute of sitting at rest. METs per week were divided into tertiles of <311, 311–344, and >344.

Anthropometric measures. Height (cm) and weight (kg) were measured using a stadiometer and balance-beam scale, and body mass index was calculated as weight (kg)/height (m)2. The waist/hip ratio was calculated using hip and waist circumference measures (cm). Body composition (body fat (percent), lean and fat mass (kg)) was determined using dual energy x-ray absorptiometry (DEXA) (Lunar Corporation, Madison, Wisconsin). The DEXA instrumentation uses a constant potential (76 kV(p) x-ray tube with K-edge filtration (350 mg/cm2)) with effective beam energies at 38 and 70 kV. Scanning speed was selected for the anterior-posterior abdominal thickness of the woman being evaluated.

Reproductive measures. Women were classified as never, former, or current users of hormone replacement therapy and oral contraceptives, based on self-report. Current use was confirmed with interviewer observation of container labels. Women were also identified as having a hysterectomy with and without double oophorectomy and confirmed by medical record.

Nutritional measures. Daily macronutrient intake was estimated from the 98-item Health Habits and History Questionnaire (13Go). The food frequency portion of the Health Habits and History Questionnaire estimates "usual past year" nutrient intake from the recall of the frequency of consumption of particular food items and portion size.

Data analysis
All statistical procedures in this analysis were performed using SAS software version 6.12 (SAS Institute, Cary, North Carolina). Univariate statistics were calculated for continuous variables, and frequency statistics were calculated for categorical variables. Testosterone concentrations were analyzed using a square root transformation, but the data presented in tables 1 through 4 have been untransformed to facilitate recognition of the units. However, the beta coefficients and standard errors in the longitudinal models (table 5) remain in their transformed state because of the complexity of the standard error measure.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Characteristics of the participants of the Michigan Bone Health Study reported from each of the three consecutive annual examinations

 

View this table:
[in this window]
[in a new window]
 
TABLE 5. Longitudinal models of testosterone concentrations (pg/ml) considering all participants (panel A), participants less than the 95th percentile of body mass index (panel B), and participants less than the 95th percentile of testosterone (panel C), Michigan Bone Health Study

 
Analysis of variance was used in comparing the mean testosterone levels and standard errors for groups at the first, second, and third examinations. The comparison groups for the cross-sectional evaluations of the data were defined by lifestyle factors and reproductive status. Regression models were used to identify those variables independently associated with testosterone concentrations from among the significant associations in the bivariate analysis.

Longitudinal mixed models were used to evaluate possible time trends and the influence of the time-varying variables (measures of body composition and ovarian status) with respect to testosterone concentrations over the 3-year period (Proc Mixed; SAS Institute). The random intercept and random slope, plus measurement error, were used to model the variability in the correlated measurements. Only those variables identified as consistently important in the cross-sectional analyses were entered into the longitudinal analyses, and then those variables that were no longer significant in an overall model were removed (i.e., lean mass), and a final longitudinal model was identified.

Because there was concern that the population might include women with undiagnosed polycystic ovary syndrome, we withdrew from analysis the data of women who were at the 95th percentile or greater of the body mass index and reran our "final model" to ensure that the same variables retained their importance. A similar process was also used for the data of women who were at the 95th percentile or greater of the baseline testosterone distribution.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The characteristics of participants are shown in table 1. Among the participants, the average age was 38 years, and the age range was 27–47 years at the last examination. Older age (within this cohort of relatively younger women) was not an important explanatory variable.

Significant increases in percent body fat, weight, and body mass index were observed among study subjects over the 3-year period (test for trend, p < 0.05). The mean amount of alcohol consumed increased somewhat, although, overall, the amounts reported were quite low. The proportion of the population that reported current smoking behavior decreased slightly. The mean level of physical activity remained constant. The prevalence of hysterectomy was 11 percent.

Lifestyle variables and testosterone concentrations
Smoking behavior was associated with increased serum testosterone levels. Women who reported that they were currently smoking had significantly higher testosterone concentrations when compared with women who did not currently smoke (table 2, p < 0.0001). The pattern among current, former, and nonsmokers was consistent at each examination. Current smokers had the highest mean levels, with mean total testosterone concentrations decreasing in former and nonsmokers.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Mean total testosterone concentrations (pg/ml) in relation to age and self-reported lifestyle behaviors including smoking practice, alcohol consumption, and amount of physical activity as measured from serum collected at three consecutive annual examinations, Michigan Bone Health Study

 
Self-reported alcohol consumption was not associated with total testosterone concentrations cross-sectionally. The mean testosterone levels did not differ significantly between drinkers and nondrinkers with the exception of the 1994-1995 examination. However, when the analysis was then restricted to only those individuals participating in all years of the study, differences in concentrations in the third examination were no longer statistically significant.

Physical activity was not associated with testosterone concentrations in any of the 3 years of examination (table 2). Women in the upper tertile of the physical activity distribution had testosterone concentrations similar to those in women in the lowest tertile of physical activity cross-sectionally and across time. The grams of protein, fat, or carbohydrate intake, as well as total energy intake (calories), were not associated with total testosterone concentrations (data not shown).

Reproductive status
Women using oral contraceptives and women using hormone replacement therapy had significantly lower testosterone concentrations than did women who were nonusers (table 3). Whereas women with oophorectomy had significantly lower testosterone concentrations than did premenopausal women, women with hysterectomy and ovarian conservation had testosterone concentrations that were not significantly different from those of premenopausal women.


View this table:
[in this window]
[in a new window]
 
TABLE 3. Mean total testosterone concentrations (pg/ml) associated with selected reproductive characteristics, from serum collected at three consecutive annual examinations, Michigan Bone Health Study

 
Body composition
Increasing weight was associated with increasing total testosterone concentration at every examination (table 4). Women in the highest body mass index category (>30 kg/m2) had testosterone concentrations that were 50–70 pg/ml higher than did women in the lowest category (<=22 kg/m2). Measures of body composition were consistently associated with testosterone concentrations in a dose-response relation. The amount of fat mass explained more variation in total testosterone than did lean body mass, although both were significantly associated with testosterone concentrations. Increased percent body fat, assessed with DEXA, was associated with higher levels of testosterone. The relation persisted following adjustment for smoking. There were no significant interactions between smoking and any of the anthropometric measures in relation to testosterone concentrations.


View this table:
[in this window]
[in a new window]
 
TABLE 4. Mean total testosterone concentrations (pg/ml) in association with measures of body composition and body topology (waist/hip ratio), from serum collected at three consecutive annual examinations, Michigan Bone Health Study

 
A greater waist circumference was associated with higher testosterone concentrations cross-sectionally. Women with a waist circumference of >=87 cm had testosterone concentrations that were 50–70 pg/ml higher than the mean concentrations in women with waist circumferences of <70 cm. Whereas there appeared to be a trend of increasing total testosterone with increasing waist/hip ratio, this association was not statistically significant across all examinations.

Independent contributors to testosterone concentrations
Cross-sectional regression models considered smoking, hormone use, oophorectomy, fat mass, lean body mass, and waist circumference simultaneously. The correlations between smoking, fat mass, hormone use, and oophorectomy and total testosterone remained statistically significant, while lean body mass and waist circumference were no longer significantly correlated.

We also evaluated the association of testosterone concentrations over time in longitudinal models considering body composition, smoking behavior, hormone use, and reproductive surgery status (table 5). Smoking behavior and increasing body mass index were each associated with increasing testosterone concentrations over time, whereas hysterectomy with oophorectomy was associated with a decline in testosterone concentrations over time. These relations were consistent whether the entire population was considered (table 5, panel A) or whether the women with the highest 5 percent of body composition were excluded from analysis (table 5, panel B). Likewise, the same variables remained important when the data from women with the highest 5 percent of testosterone concentration (table 5, panel C) were excluded in the event that they might have undiagnosed polycystic ovary syndrome.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In this population-based study, smoking behavior and measures of body composition were associated with increased serum testosterone concentrations. There were no significant associations with other lifestyle variables representing alcohol consumption, physical activity, and intake of energy and the macronutrients, protein, carbohydrate, and fat.

Smoking was associated with increased serum testosterone concentrations and after adjustment for other factors, including body mass index. Of the few studies that have previously examined smoking and androgen levels in women, the findings are highly inconsistent. Longcope and Johnston (14Go) measured the metabolic clearance rates and production rates of estrogen and androgens in smokers and nonsmokers as part of an ongoing study of hormones and osteoporosis in 88 pre- and postmenopausal women. They found that the metabolic clearance rates for smokers were lower for androstenedione, testosterone, estrone, and estradiol when compared with those of nonsmokers. However, following adjustment for weight, these differences disappeared with the exception of androstenedione. Khaw et al. (15Go) examined the relation between smoking and endogenous sex hormone levels in 233 White, postmenopausal women aged 60–79 years. Current cigarette use was positively associated with concentrations of the adrenal androgens, dehydroepiandrosterone sulfate, and androstenedione. However, mean concentrations of estrone, estradiol, sex hormone binding globulin, and testosterone did not differ significantly between smokers and nonsmokers. Thomas et al. (16Go) compared estradiol, as well as androgen and salivary progesterone, concentrations in 25 normal premenopausal smokers and 21 nonsmokers measured in a single menstrual cycle. They found no significant differences in plasma testosterone, androstenedione, and dehydroepiandrosterone concentrations.

A possible explanation for the inconsistency between our findings and those of other studies is the choice of populations to study. The Michigan Bone Health Study subjects are largely premenopausal while the other studies focused primarily on postmenopausal women or a combination of pre- and postmenopausal participants. In premenopausal women, testosterone is produced in the ovaries and adrenals, while in postmenopausal women, testosterone is produced by the adrenals and the peripheral conversion of androstenedione in adipose tissue.

We speculate that the greater concentrations of testosterone observed among current smokers were more likely a product of decreased metabolism rather than increased biosynthesis of the hormone. Longcope and Johnston (14Go) provide evidence to support this theory. Cytochrome P-450 hydroxylases are responsible for the oxidative metabolism of steroid hormones in general. These enzymes mediate the introduction of an oxygen atom (derived from water or molecular oxygen) into the steroid nucleus. P-450 hydroxylases are subject to inhibition by carbon monoxide. Smokers have greater circulating carbon monoxide concentrations as a by-product of tobacco smoke. This may inhibit P-450 hydroxylases and explain the increased concentrations of testosterone and its precursors. Thus, future studies of androgen and smoking in women need to consider products in the androgen pathway as well as the availability of bioactive testosterone, concentrations of sex hormone binding globulin, and receptor binding.

Alcohol consumption was not associated with testosterone concentrations in this study, and findings are inconsistent in other studies. For example, Cigolini et al. (17Go) observed that daily alcohol intake was positively and independently correlated with plasma-free and total testosterone in 87 light-to-moderate drinking premenopausal women, while Gavaler and VanThiel (18Go) identified increased metabolism of testosterone. One likely explanation for the contrast in findings may be related to the amount and frequency of alcohol consumption. Eighty percent of our population reported drinking <=1 drink per week, while other study populations consumed alcohol daily or in much larger quantities (4–5 drinks per week).

Testosterone concentrations did not change with the level of physical activity in our study participants, but most studies that have examined the relation between testosterone and physical activity in women have focused on female athletes or on acute changes in testosterone following heavy exercise (19GoGo–21Go).

Reproductive factors
We found that users of oral contraceptives and hormone replacement therapy had significantly lower testosterone concentrations when compared with nonusers, although hormone use was not included in the longitudinal summary models, because women with hysterectomy/oophorectomy were more likely to be using hormones leading to colinearity in the models. Our findings are consistent with those of other studies that have examined exogenous hormone use and androgen levels (22GoGoGo–25Go).

Study participants with hysterectomy/oophorectomy had significantly lower testosterone levels when compared with women who had neither procedure. Few studies have examined the relation between hysterectomy and testosterone levels, and none have made the distinction between hysterectomy with and without bilateral oophorectomy. There are two general metabolic pathways by which testosterone is produced, one via the ovary and the other via the adrenals. In the follicular tissue of the ovary and the adrenal cortex, the {delta}4 and {delta}5 pathways produce testosterone from progesterone and pregnenolone. Pregnenolone appears to be a more efficient precursor of testosterone than progesterone in ovaries without corpus luteum. Women with oophorectomy have decreased levels of testosterone because production relies primarily on the adrenal cortex and peripheral conversion of androstenedione (3Go). In a recent paper (26Go), it was argued that lower testosterone levels in women with hysterectomy are a key risk factor for cardiovascular risk and that "removal of the uterus compromises the function of the ovaries even when they are spared" (26Go, p. 829). In our study, hysterectomy with ovarian conservation was associated with significantly higher testosterone concentrations when compared with those of other participants.

Body composition and body topology variables
Body mass index, waist/hip ratio, and percent body fat were all positively associated with testosterone concentrations. Of the studies that have focused on the anthropometric predictors of androgen concentrations in women, one found a positive relation (27Go) and two found no relation after adjustment for other factors (17Go, 28Go). Increases in lean body mass were also reported to be associated with higher testosterone levels in a previous paper from this study (29Go).

It has long been appreciated that a subset of women with significantly higher androgen concentrations was more likely to be obese. Androgen metabolism is accelerated in obese individuals and is associated with lower sex hormone binding globulin levels, but it is not known whether increased clearance precedes or follows accelerated production of androgen (30Go). We evaluated whether the observed association of body composition measures and testosterone concentrations was being unduly influenced by a small group of women with hyperandrogenism (and its accompanying obesity). We reconstructed the data set to remove the contribution of those women whose total testosterone level was in the top 5 percent of the androgen distribution. Even in their absence, we still observed significant associations with body composition and smoking behavior. Likewise, because polycystic ovary syndrome is associated with obesity, we reconstructed the data set to remove the contribution of those women in the top 5 percent of the body mass index distribution. The same variables remained statistically important. This suggests that the findings of smoking, body composition, and reproductive status are not the reflection of undue influence by a subgroup of women in the population with subclinical or undiagnosed polycystic ovary syndrome.

This is one of the first papers to describe the correlates of testosterone concentrations in women and the only one that focuses largely on pre- and perimenopausal women. However, the measures are of total testosterone rather than free, bioavailable testosterone. In addition, there are other limitations in our study design. Although our sample size was large enough to detect significant differences in mean testosterone in most situations, we were unable to contrast differences between postmenopausal women and the other groups because of the small number of postmenopausal participants. In addition, a 3-year follow-up of these individuals is insufficient to assess changes in testosterone over time and with age.

In summary, past research efforts have focused primarily on the relation between estrogen and disease in women and have largely ignored testosterone in relation to health and disease states in women with the exception of a few disorders. The greater circulating levels of testosterone with obese women and smokers suggest that testosterone may be an important contribution to those disease conditions where obesity and smoking are risk factors, including cardiovascular disease.


    ACKNOWLEDGMENTS
 
This research was funded by grant AR R01-40888 from the National Institutes of Health, National Institute of Arthritis, Musculoskeletal, and Skin Diseases.

The authors thank Mary Crutchfield of the Michigan Bone Health Study and Dr. Stanley Korneman for their respective contributions.


    NOTES
 
Correspondence to Dr. MF. Sowers, Department of Epidemiology, School of Public Health, University of Michigan, 108 S. Observatory Street, Ann Arbor, MI 48109-2029 (e-mail: mfsowers{at}umich.edu).


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Fauser BC, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997;18:71–106.[Abstract/Free Full Text]
  2. Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore, MD: Williams and Wilkins, 1994:457–515.
  3. Norman AW, Litwack G. Hormones. 2nd ed. San Diego, CA: Academic Press, 1997:9–86.
  4. Zeleniuch-Jacquotte A, Bruning PF, Bonfrer JMG, et al. Relation of serum levels of testosterone and dehydro-epiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 1997;145:1030–8.[Abstract]
  5. Andersson B, Marin P, Lissner L, et al. Testosterone concentrations in women and men with NIDDM. Diabetes Care 1994;17:405–11.[Abstract]
  6. Haffner SM. Sex hormone-binding protein, hyperinsulinemia, insulin resistance and noninsulin-dependent diabetes. Horm Res 1996;45:233–7.[ISI][Medline]
  7. Sowers MF, Hochberg M, Crabbe JP, et al. Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. Am J Epidemiol 1996;143:38–47.[Abstract]
  8. Ben-Aryeth H, Abu-Nassar A, Laufer D, et al. Salivary testosterone levels in men and women: changes with age and correlation with plasma testosterone. Isr J Med Sci 1989;25:344–6.[ISI][Medline]
  9. Dai WS, Kuller LH, LaPorte RE, et al. The epidemiology of plasma testosterone levels in middle-aged men. Am J Epidemiol 1981;114:804–16.[Abstract]
  10. Zmuda JM, Cauley JA, Kriska A, et al. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men: a 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 1997;146:609–17.[Abstract]
  11. Sowers MF, Crutchfield M, Bandekar R, et al. Bone mineral density and its change in pre- and perimenopausal white women: the Michigan Bone Health Study. J Bone Miner Res 1998;13:1134–40.[ISI][Medline]
  12. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985;121:91–106.[Abstract]
  13. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453–69.[Abstract]
  14. Longcope C, Johnston CC Jr. Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers. J Clin Endocrinol Metab 1988;67:379–83.[Abstract]
  15. Khaw KT, Tazuke S, Barrett-Conner E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988;318:1705–9.[Abstract]
  16. Thomas EJ, Edridge W, Weddell A, et al. The impact of cigarette smoking on the plasma concentrations of gondaotrophins, ovarian steroids and androgens and upon the metabolism of oestrogens in the human female. Hum Reprod 1993;8:1187–93.[Abstract]
  17. Cigolini M, Targher G, Bergamo-Andreis IA, et al. Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women. Int J Obes Relat Metab Disord 1996;20:206–12.[Medline]
  18. Gavaler JS, VanThiel DH. The association between moderate alcohol beverage consumption and serum estradiol and testosterone levels in normal postmenopausal women: relationship to the literature. Alcohol Clin Exp Res 1992;16:87–92.[ISI][Medline]
  19. Tsai L, Johansson C, Pousette A, et al. Cortisol and androgen concentrations in female and male elite endurance athletes in relation to physical activity. Eur J Appl Physiol 1991;63:308–11.
  20. Cumming DC, Wall SR, Quinney HA, et al. Decrease in serum testosterone levels with maximal intensity swimming exercise in trained male and female swimmers. Endocr Res 1987;13:31–41.[ISI][Medline]
  21. Keizer H, Janssen GM, Menheere P, et al. Changes in basal plasma testosterone, cortisol, and dehydroepiandrosterone sulfate in previously untrained males and females preparing for a marathon. Int J Sports Med 1989;10(suppl):S139–45.[ISI][Medline]
  22. Moutos D, Smith S, Zacur H. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotrophins, androgens and sex hormone binding globulin: a randomized trial. Contraception 1995;52:105–9.[ISI][Medline]
  23. Coenen CM, Thomas CM, Borm GF, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996;53:171–6.[ISI][Medline]
  24. Kuhnz W, Staks T, Jutting G. Pharmacokinetics of levonorgestrel and ethinyl estradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive; serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum. Contraception 1994;50:563–79.[ISI][Medline]
  25. Tazuke S, Khaw KT, Barrett-Conner E, et al. Exogenous estrogen and endogenous sex hormones. Medicine (Baltimore) 1992;71:44–51.[ISI][Medline]
  26. Rako S. Testosterone deficiency: a key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging? J Womens Health 1998;7:825–9.[ISI][Medline]
  27. Cauley JA, Gutai JP, Kuller KH, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120–31.[Abstract]
  28. Goodman-Gruen D, Barrett-Connor E. Total but not bioavailable testosterone is a predictor of central adiposity in postmenopausal women. Int J Obes Relat Metab Disord 1995;19:293–8.[Medline]
  29. Sowers MF, Crutchfield M, Jannausch ML, et al. Longitudinal changes in women approaching the midlife. Ann Hum Biol 1996;23:253–65.[ISI][Medline]
  30. Conway GS. Polycystic ovary syndrome: clinical aspects. Baillieres Clin Endocrinol Metab 1996;10:263–79.[ISI][Medline]
Received for publication July 26, 1999. Accepted for publication March 31, 2000.